Intuitive Surgical, Inc. (NASDAQ:ISRG) Holdings Decreased by Concord Wealth Partners

Concord Wealth Partners lessened its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 7.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,092 shares of the medical equipment provider’s stock after selling 90 shares during the quarter. Concord Wealth Partners’ holdings in Intuitive Surgical were worth $570,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. Mirador Capital Partners LP raised its stake in Intuitive Surgical by 1.4% during the third quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider’s stock worth $1,732,000 after acquiring an additional 50 shares during the period. M.E. Allison & CO. Inc. acquired a new position in Intuitive Surgical during the 4th quarter valued at approximately $449,000. Seilern Investment Management Ltd bought a new position in Intuitive Surgical during the 4th quarter worth $82,517,000. Exome Asset Management LLC lifted its stake in Intuitive Surgical by 16.8% in the third quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock valued at $3,649,000 after buying an additional 1,069 shares during the last quarter. Finally, Consolidated Planning Corp boosted its holdings in shares of Intuitive Surgical by 17.4% during the third quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock valued at $3,979,000 after acquiring an additional 1,198 shares during the period. Institutional investors own 83.64% of the company’s stock.

Analysts Set New Price Targets

Several analysts recently weighed in on ISRG shares. UBS Group lifted their price objective on shares of Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a research report on Monday, January 27th. Evercore ISI upped their price objective on shares of Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. Citigroup raised their target price on shares of Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research note on Friday, January 24th. BTIG Research increased their price objective on shares of Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a report on Tuesday, November 26th. Finally, Raymond James boosted their target price on Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have given a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $613.10.

Intuitive Surgical Trading Down 1.4 %

Shares of NASDAQ ISRG opened at $571.88 on Friday. The firm has a market capitalization of $203.69 billion, a PE ratio of 89.22, a PEG ratio of 5.52 and a beta of 1.39. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00. The business has a 50-day moving average price of $550.40 and a two-hundred day moving average price of $508.94.

Insider Buying and Selling

In other news, EVP Robert Desantis sold 376 shares of the stock in a transaction on Friday, November 29th. The shares were sold at an average price of $539.00, for a total transaction of $202,664.00. Following the transaction, the executive vice president now owns 5,506 shares in the company, valued at $2,967,734. This represents a 6.39 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Jamie Samath sold 269 shares of the business’s stock in a transaction that occurred on Monday, November 11th. The stock was sold at an average price of $539.89, for a total value of $145,230.41. Following the completion of the sale, the insider now owns 8,757 shares of the company’s stock, valued at approximately $4,727,816.73. This trade represents a 2.98 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 28,843 shares of company stock worth $15,357,560. 0.90% of the stock is owned by company insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.